相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。OxLDL-induced IL-1beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation
Weiwei Liu et al.
INFLAMMATION RESEARCH (2014)
TLR4/PKC-mediated tight junction modulation: A clinical marker of chemotherapy-induced gut toxicity?
Hannah R. Wardill et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Inflammation and Atherosclerosis-Revisited
Sadip Pant et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2014)
Macrophage Activation by Heparanase Is Mediated by TLR-2 and TLR-4 and Associates With Plaque Progression
Miry Blich et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
PKC Promotes Vascular Inflammation and Acceleration of Atherosclerosis in Diabetic ApoE Null Mice
Linghua Kong et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Regulation of MSR-1 and CD36 in macrophages by LOX-1 mediated through PPAR-γ
Yao Dai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
LOX-1, a bridge between GLP-1R and mitochondrial ROS generation in human vascular smooth muscle cells
Yao Dai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Glucagon-like Peptide-1 Receptor Agonist Liraglutide Inhibits Endothelin-1 in Endothelial Cell by Repressing Nuclear Factor-Kappa B Activation
Yao Dai et al.
CARDIOVASCULAR DRUGS AND THERAPY (2013)
Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis
Anna M. Lundberg et al.
CARDIOVASCULAR RESEARCH (2013)
Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Improves Endothelial Dysfunction in Association With Its Anti-Inflammatory Effects in Patients With Coronary Artery Disease and Uncontrolled Diabetes
Junichi Matsubara et al.
CIRCULATION JOURNAL (2013)
New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy
Mitsuyoshi Namba et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2013)
Sitagliptin therapy enhances the number of circulating angiogenic cells and angiogenesis-evaluations in vitro and in the rat critical limb ischemia model
Sarah Chua et al.
CYTOTHERAPY (2013)
Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice
Nasib Ervinna et al.
ENDOCRINOLOGY (2013)
Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophages
Iryna Voloshyna et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2013)
The ATM protein kinase: regulating the cellular response to genotoxic stress, and more
Yosef Shiloh et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice
Michishige Terasaki et al.
PLOS ONE (2013)
NLRP3 activation induces ASC-dependent programmed necrotic cell death, which leads to neutrophilic inflammation
T. Satoh et al.
CELL DEATH & DISEASE (2013)
Loss of DPP4 activity is related to a prothrombogenic status of endothelial cells: implications for the coronary microvasculature of myocardial infarction patients
Paul A. J. Krijnen et al.
BASIC RESEARCH IN CARDIOLOGY (2012)
Oxidized low-density lipoprotein induces secretion of interleukin-1β by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation
Yugang Jiang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Effect of the interleukin-1B gene on serum oxidized low-density lipoprotein levels
Maria Fernanda Manica-Cattani et al.
CLINICAL BIOCHEMISTRY (2012)
Cardiovascular effects of the DPP-4 inhibitors
Tessey Jose et al.
DIABETES & VASCULAR DISEASE RESEARCH (2012)
ABCA1 Protein Enhances Toll-like Receptor 4 (TLR4)-stimulated Interleukin-10 (IL-10) Secretion through Protein Kinase A (PKA) Activation
Loretta Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Tenascin-C Produced by Oxidized LDL-Stimulated Macrophages Increases Foam Cell Formation through Toll-like Receptor-4
Rui Liu et al.
MOLECULES AND CELLS (2012)
Phosphorylation of NLRC4 is critical for inflammasome activation
Yan Qu et al.
NATURE (2012)
Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy
Harmeet Kaur et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis
Zubair Shah et al.
CIRCULATION (2011)
Ht31, a Protein Kinase A Anchoring Inhibitor, Induces Robust Cholesterol Efflux and Reverses Macrophage Foam Cell Formation through ATP-binding Cassette Transporter A1
Loretta Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1 beta in type 2 diabetes
Seth L. Masters et al.
NATURE IMMUNOLOGY (2010)
Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis
Yasushi Ishigaki et al.
CIRCULATION (2008)
Optimized THP-1 differentiation is required for the detection of responses to weak stimuli
E. K. Park et al.
INFLAMMATION RESEARCH (2007)
Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL
XH Xu et al.
CIRCULATION (2001)
Toll-like receptors and innate immunity
R Medzhitov
NATURE REVIEWS IMMUNOLOGY (2001)
Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors
JM Hayden et al.
CURRENT OPINION IN LIPIDOLOGY (2000)
分享论文
